Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs to Market Synthetic Genomics' DNA Fragment Assembly Tech

Premium

New England Biolabs and Synthetic Genomics have inked a licensing deal that will allow NEB to market a master mix based on Gibson Assembly technology for molecular and synthetic biology applications, the companies said this week.

The Gibson Assembly master mix was developed by Daniel Gibson and colleagues at the J. Craig Venter Institute as part of a program sponsored by La Jolla, Calif.-based Synthetic Genomics. Introduced in 2009, the method uses a one-step, isothermal approach to enable the rapid assembly of multiple DNA fragments.

The Gibson Assembly master mix includes protocols for primer design, and can be used to assemble multiple DNA fragments, including linearized vector and insert, into larger genetic constructs. NEB, based in Ipswich, Mass., now offers the master mix through its website, the company said.

The companies did not disclose financial details of the agreement.

SGI also noted that it recently signed an agreement with Integrated DNA Technologies to manufacture, market, and commercialize custom synthetic double-stranded nucleic acids of lengths up to 5 kb using SGI's proprietary technologies.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.